According to several reports in the last few years, desoxypyridinoline (Dpd
) in urine increases significantly in cases of loosened arthroplasty. There
fore, this marker was suggested as useful in the diagnostics of implant loo
sening. In this study, the level of Dpd was determined in 69 patients with
arthroplasty of the hip or the knee joint. Thirty-four of these patients re
ceived revision surgery following implant loosening. In 35 of these 69 pati
ents, there were no clinical or radiological signs of loosening (control gr
oup). The mean age of the patients with loosened implants (22 women, 13 men
) was 67.9 years and of the control group (22 women, 12 men) 66.9 years. In
the group with arthroplastic loosening, as well as in the control group, 1
4 patients had increased levels of Dpd. There were 20 patients in the group
with loosened arthroplasty and 19 patients in the control group that had n
ormal levels of Dpd. The female patients had a mean Dpd level of X.6 nmol/m
mol creatinine (4.3-24 nmol/mmol creatinine) in the urine in cases of loose
ning and 10.1 nmol/mmol creatinine (2-33 nmol/mmol creatinine) in the contr
ol group. The male patients had a mean Dpd level of 7.8 nmol/mmol creatinin
e (3.2-19.2 nmol/mmol creatinine) in the urine in cases of loosening and 5.
8 nmol/mmol creatinine (0.3-11.7 nmol/mmol creatinine) in the control group
. In conclusion there was no significant increase in Dpd in patients with i
mplant loosening compared with the control group. Furthermore, older patien
ts often suffer from diseases causing increased bone resorption that may fa
lsify the test results. We cannot confirm that Dpd is helpful in the diagno
stics and screening of implant loosening.